| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |